CPHI P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.73
Average-0.8295
Median-0.7450
Minimum-1.05
Maximum-0.6800
-0.73
Past Month+0.32 (30.48%)
The P/E ratio for CPHI is -0.73 as of Jun 13, 2025. This represents a decrease of -84.06% compared to its 12-month average P/E ratio of -4.58. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
China Pharma Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
China Pharma Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing China Pharma Holdings to industry peers.
China Pharma Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
China Pharma Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing China Pharma Holdings to industry peers.
CPHI P/E Ratio Insights
See China Pharma Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CPHI
Order type
Buy in
Order amount
Est. shares
0 shares
CPHI P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $1.68 | -0.75 |
| May 1, 2025 | $1.98 | -0.73 |
| Apr 1, 2025 | $2.4505 | -8.99 |
| Mar 3, 2025 | $1.95 | -5.69 |
| Feb 3, 2025 | $2.227 | -6.50 |
| Jan 2, 2025 | $2.39 | -6.98 |
CPHI End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.73 | -89.25% |
| 2024 | -6.79 | +110.87% |
| 2023 | -3.22 | -74.28% |
| 2022 | -12.52 | -80.90% |
| 2021 | -65.56 | -3.35% |
| 2020 | -67.83 | — |
FAQs About China Pharma Holdings (CPHI) P/E ratio
The latest P/E ratio of CPHI is -0.73, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
China Pharma Holdings’s last 12-month average P/E ratio is -4.58, compared to its current P/E ratio of -0.73. This reflects a decrease of -84.06%.
China Pharma Holdings’s current P/E ratio of -0.73 is lower than its last 12-month average P/E of -4.58. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
China Pharma Holdings’s average P/E ratio over the last 3 years is -8.03. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
China Pharma Holdings’s average P/E ratio over the last 5 years is -29.73. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.